<?xml version="1.0" encoding="UTF-8"?>
<p>We discuss four key elements of trial design: randomization unit, trial population, comparator intervention, and trial implementation. We weave into that discussion three important ethical considerations: the social and scientific value of the trial, its riskâ€“benefit profile, and the fairness of participant selection [
 <xref rid="pmed.1002632.ref008" ref-type="bibr">8</xref>,
 <xref rid="pmed.1002632.ref009" ref-type="bibr">9</xref>]. These aspects are, in our views, key to trial design in these settings.
</p>
